CO24 Simulating the Impact of First-Line Treatment Choice on Survival Among Patients with Locally Advanced/Metastatic Urothelial Carcinoma Considered Cisplatin Ineligible
Abstract
Authors
M.D. Galsky G.P. Sonpavde B. Bloudek M. Farrar Z. Hepp J. Timmons R. Dillon T. Powles